Investment Analysts’ Updated EPS Estimates for May 12th (AGM, AMPH, ANIP, AQN, ASND, ATLC, ATNM, AVAV, BLND, BTDR)

Investment Analysts’ updated eps estimates for Monday, May 12th:

Federal Agricultural Mortgage (NYSE:AGM) had its market perform rating reaffirmed by analysts at Keefe, Bruyette & Woods. They currently have a $215.00 target price on the stock, down from their previous target price of $230.00.

Amphastar Pharmaceuticals (NASDAQ:AMPH) had its neutral rating reaffirmed by analysts at JPMorgan Chase & Co.. They currently have a $30.00 price target on the stock, down from their previous price target of $45.00.

ANI Pharmaceuticals (NASDAQ:ANIP) had its buy rating reiterated by analysts at Guggenheim. They currently have a $86.00 target price on the stock.

Algonquin Power & Utilities (NYSE:AQN) had its market perform rating reiterated by analysts at BMO Capital Markets. They currently have a $6.00 target price on the stock, up from their previous target price of $5.00.

Ascendis Pharma A/S (NASDAQ:ASND) had its overweight rating reiterated by analysts at Cantor Fitzgerald. They currently have a $200.00 target price on the stock.

Atlanticus (NASDAQ:ATLC) had its market perform rating reiterated by analysts at Keefe, Bruyette & Woods. Keefe, Bruyette & Woods currently has a $60.00 target price on the stock, up from their previous target price of $52.00.

Actinium Pharmaceuticals (NYSE:ATNM) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $4.00 price target on the stock.

AeroVironment (NASDAQ:AVAV) had its outperform rating reissued by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $190.00 target price on the stock.

Blend Labs (NYSE:BLND) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $5.25 price target on the stock.

Bitdeer Technologies Group (NASDAQ:BTDR) had its buy rating reaffirmed by analysts at Benchmark Co.. The firm currently has a $24.00 price target on the stock.

CarGurus (NASDAQ:CARG) had its outperform rating reaffirmed by analysts at Royal Bank of Canada. The firm currently has a $42.00 target price on the stock.

Chegg (NYSE:CHGG) had its hold rating reiterated by analysts at Needham & Company LLC.

COMPASS Pathways (NASDAQ:CMPS) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $45.00 price target on the stock.

Coinbase Global (NASDAQ:COIN) had its buy rating reaffirmed by analysts at Rosenblatt Securities. The firm currently has a $260.00 price target on the stock.

DocGo (NASDAQ:DCGO) had its hold rating reaffirmed by analysts at Canaccord Genuity Group Inc.. Canaccord Genuity Group Inc. currently has a $1.45 price target on the stock, down from their previous price target of $5.00.

DoubleVerify (NYSE:DV) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $18.00 target price on the stock.

DXC Technology (NYSE:DXC) had its neutral rating reaffirmed by analysts at Guggenheim.

Enbridge (NYSE:ENB) (TSE:ENB) had its outperform rating reissued by analysts at Royal Bank of Canada. The firm currently has a $67.00 price target on the stock.

BitFuFu (NASDAQ:FUFU) had its buy rating reissued by analysts at HC Wainwright. They currently have a $7.00 price target on the stock.

Hut 8 (NASDAQ:HUT) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They currently have a $32.00 target price on the stock.

ImmunityBio (NASDAQ:IBRX) had its buy rating reaffirmed by analysts at D. Boral Capital. The firm currently has a $30.00 price target on the stock.

ImmunityBio (NASDAQ:IBRX) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $8.00 price target on the stock.

Insmed (NASDAQ:INSM) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $90.00 target price on the stock.

Kymera Therapeutics (NASDAQ:KYMR) had its buy rating reiterated by analysts at Guggenheim. Guggenheim currently has a $52.00 target price on the stock.

Liquidia (NASDAQ:LQDA) had its buy rating reissued by analysts at HC Wainwright. They currently have a $29.00 price target on the stock.

Liquidia (NASDAQ:LQDA) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $25.00 price target on the stock.

ModivCare (NASDAQ:MODV) had its market perform rating reiterated by analysts at Barrington Research.

Nektar Therapeutics (NASDAQ:NKTR) had its market perform rating reaffirmed by analysts at William Blair.

OmniAb (NASDAQ:OABI) had its buy rating reissued by analysts at Benchmark Co.. Benchmark Co. currently has a $6.00 price target on the stock.

Ocugen (NASDAQ:OCGN) had its buy rating reaffirmed by analysts at Chardan Capital. Chardan Capital currently has a $7.00 price target on the stock.

PAR Technology (NYSE:PAR) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $90.00 price target on the stock.

Planet Fitness (NYSE:PLNT) had its buy rating reaffirmed by analysts at Guggenheim. Guggenheim currently has a $110.00 price target on the stock.

Papa Johns International (NASDAQ:PZZA) had its buy rating reiterated by analysts at Benchmark Co.. The firm currently has a $50.00 target price on the stock.

uniQure (NASDAQ:QURE) had its buy rating reissued by analysts at Guggenheim. The firm currently has a $28.00 target price on the stock.

uniQure (NASDAQ:QURE) had its buy rating reaffirmed by analysts at Chardan Capital. The firm currently has a $38.00 target price on the stock.

Roku (NASDAQ:ROKU) had its buy rating reiterated by analysts at Needham & Company LLC. They currently have a $88.50 price target on the stock.

Sportradar Group (NASDAQ:SRAD) had its buy rating reaffirmed by analysts at Needham & Company LLC. The firm currently has a $27.00 target price on the stock.

Surrozen (NASDAQ:SRZN) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $32.00 target price on the stock.

SpringWorks Therapeutics (NASDAQ:SWTX) had its neutral rating reaffirmed by analysts at Guggenheim. Guggenheim currently has a $47.00 price target on the stock.

Trex (NYSE:TREX) had its buy rating reissued by analysts at Benchmark Co.. They currently have a $80.00 target price on the stock.

Tevogen Bio (NASDAQ:TVGN) had its buy rating reaffirmed by analysts at D. Boral Capital. They currently have a $10.00 price target on the stock.

United States Antimony (NYSE:UAMY) had its buy rating reaffirmed by analysts at D. Boral Capital. The firm currently has a $5.00 price target on the stock.

Ubiquiti (NYSE:UI) had its buy rating reissued by analysts at BWS Financial. They currently have a $440.00 target price on the stock.

US Foods (NYSE:USFD) had its buy rating reaffirmed by analysts at Guggenheim. The firm currently has a $80.00 target price on the stock.

Walmart (NYSE:WMT) had its outperform rating reaffirmed by analysts at Telsey Advisory Group. The firm currently has a $115.00 price target on the stock.

Xponential Fitness (NYSE:XPOF) had its buy rating reaffirmed by analysts at Guggenheim. They currently have a $13.00 price target on the stock.